Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs

BACKGROUND AND OBJECTIVE: Patients with rheumatic disease taking long-term disease-modifying anti-rheumatic drugs (DMARDs) are expected to have a higher risk of infection due to the alterations in cellular immunity associated with these medications. However, the potential risks associated with these...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousefghahari, Behnaz, Navari, Sanaz, Sadeghi, Mahmoud, Soleimaniamiri, Shima, Soleimaniamiri, Mohammadjafar, Heidari, Behzad, Babaei, Mansour, Ghodrati, Kian, Guran, Ardeshir, Gholinia, Hemmat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164488/
https://www.ncbi.nlm.nih.gov/pubmed/34052904
http://dx.doi.org/10.1007/s10067-021-05779-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164488/
https://www.ncbi.nlm.nih.gov/pubmed/34052904
http://dx.doi.org/10.1007/s10067-021-05779-4

Ejemplares similares